PureTech Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-65.7	-50.35	-60.56	5.99	421.14	-43.65	26.47
Depreciation & Amortization	4.93	8.89	7.29	6.65	6.67	2.78	2.1
Share-Based Compensation	4.42	14.7	13.95	10.72	14.47	12.64	11.85
Other Operating Activities	-49.57	-152.03	-118.95	-155.18	-540.43	-44.56	-129.11
Operating Cash Flow	-105.92	-178.79	-158.27	-131.83	-98.16	-72.8	-88.69
Capital Expenditures	0.8	-2.18	-5.54	-5.17	-12.14	-4.24	-2.09
Acquisitions	-30.63	-20.44	-15	-10	-29.71	-16.89	-16.34
Change in Investments	99.01	-85.02	217.63	379.55	105.71	-18.39	102.19
Other Investing Activities	-0.18	0.42	0.29	0.1	-0.21	-0.13	-0.08
Investing Cash Flow	68.99	-107.22	197.38	364.48	63.66	-39.65	83.68
Share Issuance / Repurchase	-18.5	-26.16	-10.4	-11.85	0.5	-0.04	-0.07
Debt Issued / Paid	-3.34	-3.63	-1.16	36.88	-0.25	5.96	2.45
Other Financing Activities	99.98	-0.04	34.28	13.84	49.66	150.96	12.31
Financing Cash Flow	78.14	-29.83	22.73	38.87	49.91	156.89	14.7
Exchange Rate Effect	0	0	0	0	-0.1	-0.04	-0
Net Cash Flow	41.22	-315.84	61.83	271.52	15.31	44.4	9.69
Free Cash Flow	-105.12	-180.97	-163.82	-137	-110.29	-77.04	-90.78
Free Cash Flow Margin	-3156.82%	-1158.71%	-942.12%	-1164.15%	-1124.65%	-371.29%	-3580.91%
Free Cash Flow Per Share	-3.77	-6.29	-5.73	-4.79	-3.86	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).